With 1.75 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.45 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $285.995 whereas the lowest price it dropped to was $276.8001. The 52-week range on VEEV shows that it touched its highest point at $291.68 and its lowest point at $176.41 during that stretch. It currently has a 1-year price target of $294.33. Beta for the stock currently stands at 0.99.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VEEV was up-trending over the past week, with a rise of 1.69%, but this was up by 18.29% over a month. Three-month performance surged to 18.23% while six-month performance rose 19.18%. The stock gained 55.94% in the past year, while it has gained 34.76% so far this year. A look at the trailing 12-month EPS for VEEV yields 4.72 with Next year EPS estimates of 8.33. For the next quarter, that number is 1.90. This implies an EPS growth rate of 16.05% for this year and 8.81% for next year. EPS is expected to grow by 14.11% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 17.84%.
Float and Shares Shorts:
At present, 162.98 million VEEV shares are outstanding with a float of 149.31 million shares on hand for trading. On 2025-05-15, short shares totaled 4.39 million, which was 270.0 higher than short shares on 1744675200. In addition to Mr. Peter P. Gassner as the firm’s Founder, CEO & Director, Ms. Eleni Nitsa Zuppas serves as its President & Chief of Staff.
Institutional Ownership:
Through their ownership of 0.86535 of VEEV’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-04-30, VEEV reported revenue of $759043000.0 and operating income of $233732000.0. The EBITDA in the recently reported quarter was $243554000.0 and diluted EPS was $1.37.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VEEV since 17 analysts follow the stock currently. There are 14 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With VEEV analysts setting a high price target of 335.0 and a low target of 210.0, the average target price over the next 12 months is 291.64966. Based on these targets, VEEV could surge 18.24% to reach the target high and fall by -25.88% to reach the target low. Reaching the average price target will result in a growth of 2.94% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $4.77967 being high and $4.74967 being low. For VEEV, this leads to a yearly average estimate of $4.75967.
